FDA Inspection
Fresenius Kabi Austria GmbhFresenius Kabi Austria Gmbh – FDA Inspection, Mar 24, 2017
Record Details
This FDA Inspection record concerns Fresenius Kabi Austria Gmbh, with an inspection on March 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5de8cbe2-2f09-4d2d-9e06-6ffd76d8f8d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1006761
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Fresenius Kabi Austria Gmbh
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2025 | Not classified | Office of Inspections and Investigations | |
| July 15, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | Not classified | Office of Inspections and Investigations | |
| November 7, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Austria Gmbh
- FDA Inspection 1301512 - 2025-05-23
- FDA Inspection 1199272 - 2021-07-15
- FDA Inspection 1110698 - 2018-09-27
- FDA Inspection 906758 - 2014-11-07
- FDA Inspection 741633 - 2011-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.